Neimeth profit hits N1.5bn, advocates patient capital

Neimeth Pharmaceuticals Plc has returned to strong profitability, posting a Profit Before Tax of N1.48 billion for the financial year ended December 31, 2025, as management called on investors to embrace “patient capital” to sustain the company’s long-term expansion drive. Speaking at the company’s 2026 Annual Media Briefing, the Managing Director/Chief Executive Officer, Pharm. J.

Read More